Literature DB >> 15696323

Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.

Andrew C Harris1, Jonathan C Gewirtz.   

Abstract

RATIONALE: While opioid withdrawal is typically studied under conditions of chronic (i.e., continuous) drug administration, withdrawal signs can also be demonstrated in both humans and animals after a single opioid exposure. This phenomenon, termed acute dependence, may be useful in understanding the early stages of opioid dependence and addiction.
OBJECTIVE: This review provides an overview of acute dependence by comparing withdrawal from acute and chronic opioid exposure across dimensions ranging from symptomatology to neural substrates. Assessment of repeated withdrawals from acute opioid administration is also presented as a tool for better understanding the adaptive changes induced by multiple drug exposures.
CONCLUSIONS: Although not identical phenomena, acute and chronic dependence share a number of characteristics. Examining potentiations of withdrawal severity across multiple acute opioid exposures may be especially valuable in characterizing the development of drug dependence. Further study of acute dependence promises to lead to more effective treatments for opioid withdrawal and addiction.

Entities:  

Mesh:

Year:  2005        PMID: 15696323     DOI: 10.1007/s00213-005-2155-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  168 in total

Review 1.  The role of the striatopallidal and extended amygdala systems in drug addiction.

Authors:  G F Koob
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

2.  Effects of single doses of N-Allylnormorphine on hindlimb reflexes of chronic spinal dogs during cycles of morphine addiction.

Authors:  A WIKLER; R L CARTER
Journal:  J Pharmacol Exp Ther       Date:  1953-09       Impact factor: 4.030

Review 3.  Opposing roles of the amygdala and dorsolateral periaqueductal gray in fear-potentiated startle.

Authors:  D L Walker; J V Cassella; Y Lee; T C De Lima; M Davis
Journal:  Neurosci Biobehav Rev       Date:  1997-11       Impact factor: 8.989

4.  Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats.

Authors:  J U Adams; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

5.  Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.

Authors:  K C Kirby; M L Stitzer; S J Heishman
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

6.  Opiate withdrawal in the neonatal rat: relationship to duration of treatment and naloxone dose.

Authors:  P Ceger; C M Kuhn
Journal:  Psychopharmacology (Berl)       Date:  2000-06       Impact factor: 4.530

7.  Opiate dependence following acute injections of morphine and naloxone: the assessment of various withdrawal signs.

Authors:  R F Ritzmann
Journal:  Pharmacol Biochem Behav       Date:  1981-04       Impact factor: 3.533

8.  Morphine: conditioned increases in self-administration in rhesus monkeys.

Authors:  S R Goldberg; J H Woods; C R Schuster
Journal:  Science       Date:  1969-12-05       Impact factor: 47.728

9.  Effects of N-methylnaloxone and N-methylnaltrexone on nociception and precipitated abstinence in mice.

Authors:  K Ramabadran
Journal:  Life Sci       Date:  1982 Sep 20-27       Impact factor: 5.037

10.  Morphine no longer blocks gastrointestinal transit but retains antinociceptive action in diallylnormorphine-pretreated rats.

Authors:  A Tavani; G Bianchi; L Manara
Journal:  Eur J Pharmacol       Date:  1979-10-26       Impact factor: 4.432

View more
  27 in total

1.  Episodic withdrawal promotes psychomotor sensitization to morphine.

Authors:  Patrick E Rothwell; Jonathan C Gewirtz; Mark J Thomas
Journal:  Neuropsychopharmacology       Date:  2010-09-01       Impact factor: 7.853

2.  Protracted manifestations of acute dependence after a single morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

3.  Rapid neuroadaptation in the nucleus accumbens and bed nucleus of the stria terminalis mediates suppression of operant responding during withdrawal from acute opioid dependence.

Authors:  S H Criner; J Liu; G Schulteis
Journal:  Neuroscience       Date:  2006-12-11       Impact factor: 3.590

4.  The α3β4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies.

Authors:  P P Muldoon; K J Jackson; E Perez; J L Harenza; S Molas; B Rais; H Anwar; N T Zaveri; R Maldonado; U Maskos; J M McIntosh; M Dierssen; M F Miles; X Chen; M De Biasi; M I Damaj
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 5.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

6.  Effects of repeated morphine on ultrasonic vocalizations in adult rats: increased 50-kHz call rate and altered subtype profile.

Authors:  Laura M Best; Leah L Zhao; Tina Scardochio; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2016-10-11       Impact factor: 4.530

7.  Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake.

Authors:  Nathan A Holtz; Anna K Radke; Natalie E Zlebnik; Andrew C Harris; Marilyn E Carroll
Journal:  Brain Res       Date:  2015-01-09       Impact factor: 3.252

8.  Higher anhedonia during withdrawal from initial opioid exposure is protective against subsequent opioid self-administration in rats.

Authors:  Yayi Swain; Peter Muelken; Annika Skansberg; Danielle Lanzdorf; Zachary Haave; Mark G LeSage; Jonathan C Gewirtz; Andrew C Harris
Journal:  Psychopharmacology (Berl)       Date:  2020-05-09       Impact factor: 4.530

9.  Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia.

Authors:  Andrew C Harris; Patrick E Rothwell; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2007-11-16       Impact factor: 4.530

10.  Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption.

Authors:  David A White; Michael E Ballard; Alvin C Harmon; Stephen G Holtzman
Journal:  Brain Res Bull       Date:  2008-05-09       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.